These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 31136822)
61. Targeting inhibitory Siglec-3 to suppress IgE-mediated human basophil degranulation. Barshow SM; Islam M; Commins S; Macauley MS; Paulson JC; Kulis MD J Allergy Clin Immunol; 2024 Aug; 154(2):492-497.e1. PubMed ID: 38593870 [TBL] [Abstract][Full Text] [Related]
62. Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria. Oliver ET; Sterba PM; Saini SS Allergy; 2015 May; 70(5):601-3. PubMed ID: 25631394 [TBL] [Abstract][Full Text] [Related]
63. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab. Maronese CA; Ferrucci SM; Moltrasio C; Lorini M; Carbonelli V; Asero R; Marzano AV; Cugno M J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615181 [No Abstract] [Full Text] [Related]
64. A human monoclonal IgE antibody that binds to MGL_1304, a major allergen in human sweat, without activation of mast cells and basophils. Ishii K; Hiragun M; Hiragun T; Kan T; Kawaguchi T; Yanase Y; Tanaka A; Takahagi S; Hide M Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):99-104. PubMed ID: 26541454 [TBL] [Abstract][Full Text] [Related]
65. Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals. Cassard L; Sperber K; Buivan TP; Cotillard A; Bourdet-Sicard R; Albert ML; Mottez E; Laurent J; Guinnepain MT; Daëron M J Allergy Clin Immunol; 2018 Nov; 142(5):1548-1557. PubMed ID: 29366701 [TBL] [Abstract][Full Text] [Related]
66. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria. Magen E; Waitman DA; Kahan NR Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397 [No Abstract] [Full Text] [Related]
67. IgE- and FcepsilonRI-mediated migration of human basophils. Suzukawa M; Hirai K; Iikura M; Nagase H; Komiya A; Yoshimura-Uchiyama C; Yamada H; Ra C; Ohta K; Yamamoto K; Yamaguchi M Int Immunol; 2005 Sep; 17(9):1249-55. PubMed ID: 16103029 [TBL] [Abstract][Full Text] [Related]
68. Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria. Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2078-2085. PubMed ID: 31954076 [TBL] [Abstract][Full Text] [Related]
69. Detection of Low-Molecular-Weight Mast Cell-Activating Factors in Serum From Patients With Chronic Spontaneous Urticaria. Cugno M; Tedeschi A; Frossi B; Bossi F; Marzano AV; Asero R J Investig Allergol Clin Immunol; 2016; 26(5):310-313. PubMed ID: 27763857 [TBL] [Abstract][Full Text] [Related]
70. Unveiling chronic spontaneous urticaria pathophysiology through systems biology. Segú-Vergés C; Gómez J; Terradas-Montana P; Artigas L; Smeets S; Ferrer M; Savic S J Allergy Clin Immunol; 2023 Apr; 151(4):1005-1014. PubMed ID: 36587849 [TBL] [Abstract][Full Text] [Related]
71. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. Yu L; Buttgereit T; Stahl Skov P; Schmetzer O; Scheffel J; Kocatürk E; Zawar V; Magerl M; Maurer M J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1747-1754. PubMed ID: 31025425 [TBL] [Abstract][Full Text] [Related]
72. IgE- and FcepsilonRI-mediated enhancement of surface CD69 expression in basophils: role of low-level stimulation. Suzukawa M; Komiya A; Yoshimura-Uchiyama C; Kawakami A; Koketsu R; Nagase H; Iikura M; Yamada H; Ra C; Ohta K; Yamamoto K; Yamaguchi M Int Arch Allergy Immunol; 2007; 143 Suppl 1():56-9. PubMed ID: 17541278 [TBL] [Abstract][Full Text] [Related]